Crossmark

Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway

Crossref DOI link: https://doi.org/10.1038/s41418-020-0522-3

Published Online: 2020-03-09

Published Print: 2020-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sotomayor-Flores, Cristian https://orcid.org/0000-0001-8988-6167
Rivera-Mejías, Pablo https://orcid.org/0000-0002-5874-4112
Vásquez-Trincado, César https://orcid.org/0000-0003-2606-6860
López-Crisosto, Camila https://orcid.org/0000-0003-1055-099X
Morales, Pablo E. https://orcid.org/0000-0003-1802-8135
Pennanen, Christian

Polakovicova, Iva https://orcid.org/0000-0002-4505-9896
Aliaga-Tobar, Víctor https://orcid.org/0000-0002-4021-0112
García, Lorena https://orcid.org/0000-0002-7775-5087
Roa, Juan Carlos https://orcid.org/0000-0001-8313-8774
Rothermel, Beverly A. https://orcid.org/0000-0001-9037-6703
Maracaja-Coutinho, Vinicius https://orcid.org/0000-0002-8873-9381
Ho-Xuan, Hung https://orcid.org/0000-0003-2911-1559
Meister, Gunter

Chiong, Mario https://orcid.org/0000-0002-5174-6545
Ocaranza, María Paz https://orcid.org/0000-0002-4915-6378
Corvalán, Alejandro H. https://orcid.org/0000-0001-5492-3853
Parra, Valentina https://orcid.org/0000-0002-0080-6472
Lavandero, Sergio https://orcid.org/0000-0003-4258-1483
License Information

Text and Data Mining valid from 2020-03-09

Version of Record valid from 2020-03-09
More Information

Article History

Received: 9 July 2019

Revised: 19 February 2020

Accepted: 24 February 2020

First Online: 9 March 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.